{
  "@context": "aku-v2",
  "@type": "procedure",
  "@id": "vasc:procedures:thrombectomy-002-pharmacomechanical",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T02:35:00.000Z",
    "updated": "2026-01-07T02:35:00.000Z",
    "contributors": [
      "vascular-surgery-agent"
    ],
    "confidence": 0.92,
    "status": "enhanced",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/procedures/thrombectomy",
    "type": "procedure",
    "difficulty": "advanced",
    "importance": "core"
  },
  "content": {
    "title": "Pharmacomechanical Catheter-Directed Thrombolysis",
    "description": "Combined approach using thrombolytic drugs delivered through specialized catheters with or without mechanical adjuncts to accelerate thrombus dissolution.",
    "components": {
      "thrombolytic_agents": [
        "tPA (alteplase)",
        "Reteplase",
        "Tenecteplase"
      ],
      "delivery_methods": [
        "Multi-sidehole catheter infusion",
        "Ultrasound-assisted (EKOS)",
        "Power-pulse spray (AngioJet)"
      ],
      "mechanical_adjuncts": [
        "Balloon maceration",
        "Rheolytic thrombectomy",
        "Aspiration"
      ]
    },
    "EKOS_ultrasound_assisted": {
      "mechanism": "Ultrasound loosens fibrin matrix, enhances drug penetration",
      "advantages": "May allow lower lytic dose, faster resolution",
      "evidence": "ATTRACT trial data"
    },
    "protocol_example": {
      "access": "Establish access beyond thrombus if possible",
      "catheter_placement": "Infusion catheter spanning thrombus",
      "tPA_dose": "0.5-1 mg/hr typical (varies by protocol)",
      "check_intervals": "Reimage at 12-24 hours",
      "endpoints": "Complete lysis or conversion to mechanical therapy"
    },
    "monitoring": [
      "Fibrinogen levels",
      "Clinical exam",
      "Repeat imaging"
    ],
    "complications": {
      "bleeding": "Major bleeding 5-10%",
      "ich": "Intracranial hemorrhage 0.5-1%"
    },
    "statement": "Pharmacomechanical Catheter-Directed Thrombolysis is a fundamental concept in Health-Sciences Medicine Surgery Vascular Procedures Thrombectomy that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Pharmacomechanical Catheter-Directed Thrombolysis helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Pharmacomechanical Catheter-Directed Thrombolysis include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Pharmacomechanical Catheter-Directed Thrombolysis."
    }
  },
  "relationships": {
    "related_to": [
      "vasc:procedures:thrombectomy-001-mechanical",
      "vasc:dvt:treatment"
    ],
    "used_in": [
      "vasc:ali:thrombolysis",
      "vasc:venous:dvt-thrombolysis"
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). Pharmacomechanical Catheter-Directed Thrombolysis. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}